Using mathematical modeling and dynamic biomarkers to characterize metastatic disease during adaptive therapy

Most cancer deaths are due to the metastatic spread and growth of tumor cells at distant sites. Identifying appropriate treatments for patients with metastatic disease is challenging because of limited biomarkers and detection capabilities, and poor characterization of metastatic tumors.

Leave A Comment

Your email address will not be published. Required fields are marked *